Search alternatives:
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
-
21
Mean values (± standard deviation) of electrolyte concentrations before and after CWI.
Published 2025Subjects: -
22
a) Number weighted mean volume of AEII during postnatal development and in adults. There are no volume alterations before and at the end of bulk alveolarization. A significant increase was determined in adults compared to 3 and 7 days old pups. b) Size of AEII presented as V<sub>S</sub>-ratioAEII during postnatal lung development into adulthood. Before and during bulk alveolarization there are no size changes. Adults show a significant increase compared to values before and at onset of alveolarization. c) Number weighted mean volume of AEII per lung volume during postnatal development and in adults. The highest values are seen before alveolarization. During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21....
Published 2025“…During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21. …”
-
23
Decreased synthesis of VCAM-1, tubulin and dynein proteins in the heart of mice stimulated with EVs (green) or ICs (blue).
Published 2025“…The values represent the mean ± SEM, with significance set at p < 0.05 (*).…”
-
24
-
25
Mean values (± standard deviation) of liver profile parameters before and after CWI.
Published 2025Subjects: -
26
Mean values (± standard deviation) of renal profile parameters before and after CWI.
Published 2025Subjects: -
27
Mean values (± standard deviation) of lipid profile parameters before and after CWI.
Published 2025Subjects: -
28
-
29
-
30
-
31
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
32
-
33
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
34
-
35
-
36
-
37
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
38
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
39
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
40
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: